Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 70518-4739

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 70518-4739). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label of Bupropion HCl extended-release (XL) tablets, 300 mg strength, containing 90 tablets. The label notes the product is repackaged by RemedyRepack Inc., Indiana, PA. It includes warnings about use with Zyban, storage instructions, and dosage guidance referencing an insert. The label also displays the NDC number 70518-4739-00.*

FDA Label Image

Bupropion-structure.jpg (Bupropion Structure)

Chemical structure of bupropion hydrochloride showing the molecular arrangement including a chlorophenyl group, a ketone, and a tert-butylamino side chain with HCl indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.